Citations

Mayo Clinic

Showing 10 of 108376 citations.

Author's Reply
Elhassan, Bassem T. , Warner, Jon J.P.

Arthroscopy | April 29, 2010 | Volume: 26 | Issue: 6 | Pages: 727-728

10.1016/j.arthro.2009.12.002 Get It

Evaluation of the Bio-Rad BioPlex 2200 Syphilis Multiplex Flow Immunoassay for the Detection of IgM- and IgG-Class Antitreponemal Antibodies
Gomez, Eric, Jespersen, Deborah J., Harring, Julie, Binnicker, Matthew J.

Clinical and Vaccine Immunology | April 29, 2010 | Volume: 17 | Issue: 6 | Pages: 966-968

10.1128/cvi.00086-10 | PMID 20427627 Get It

ABSTRACT The laboratory diagnosis of syphilis is based primarily upon serologic findings. Historically, serologic testing for syphilis has relied on assays such as rapid plasma reagin, fluorescent treponemal antibody absorption, Treponema pallidum particle agglutination (TP-PA), and more recently, enzyme immunoassay (EIA). In this study, we evaluated the performance of a novel multiplex flow immunoassay (BioPlex 2200 Syphilis; Bio-Rad Laboratories, Hercules, CA) for the detection of antitreponemal IgG- and IgM-class antibodies. Serum specimens ( n = 1,008) submitted for routine treponema-specific antibody testing by syphilis IgM and IgG EIA (Trep-Chek; Phoenix-Biotech, Mississauga, Ontario, Canada) were also analyzed by the BioPlex Syphilis multiplex assay. Specimens showing discordant results were repeat tested, with further discrepancies being arbitrated by TP-PA. Compared directly to the results of EIA, the BioPlex IgG assay demonstrated 98.7% (77/78) sensitivity and 99.4% (916/930) specificity. Compared to the Trep-Chek IgM EIA, the BioPlex IgM assay showed 80% (4/5) sensitivity and 97.9% (652/666) specificity. These results indicate that the BioPlex Syphilis multiplex assay shows similar serological agreement with EIA while allowing for a fully automated random-access platform that provides faster (1.7 h for 100 samples versus 4.5 h by EIA) and higher-throughput (800 samples per 9 h versus 200 samples by EIA) analysis of the syphilis serologic response.
Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups
Colón‐Otero, Gerardo , Hume, Celyne Bueno , Copland, John A. , Perez, Edith A. , Patel, Tejal Amar

The Oncologist | April 29, 2010 | Volume: 15 | Issue: 5 | Pages: 466-475

10.1634/theoncologist.2010-0004 | PMID 20427382 Get It

Abstract Disparities in clinical outcomes of breast cancer have been described among different racial and ethnic groups in the U.S. Convincing data exist showing that Latina women have a lower incidence of breast cancer but a higher breast cancer–related mortality rate compared with white women. Noticeable differences in breast cancer incidence are present even within different Latina subsets with a higher incidence in second- and third-generation women compared with foreign born. An increasing amount of data exists pointing to significant differences in the genetics and biology of breast cancer in Latinas as a significant contributor to the higher mortality, including a higher incidence of triple-negative breast cancers (which do not overexpress HER-2 protein and are negative for estrogen receptors and progesterone receptors). Other social and environmental factors are likely to play a significant role as well, including a lower rate of screening mammography, variable access to medical care, among others. Recent data are inconclusive regarding differences among racial/ethnic groups in the response to chemotherapy. Data on racial/ethnic variations in the pharmacogenomics of chemotherapy, endocrine treatments, and toxicity are more limited, with some data suggesting differences in frequencies of polymorphisms of genes involved in the metabolism of some of these agents. Further studies are needed on this subject.
A window of opportunity for no treatment in early multiple sclerosis?
Gilmore, CP, Cottrell, DA, Scolding, Neil , Wingerchuk, D. M., Weinshenker, B. G., Boggild, M., Weinshenker, Brian G. , Cottrell, David A., Weinshenker, Brian G

Multiple Sclerosis Journal | April 28, 2010 | Volume: 16 | Issue: 6 | Pages: 756-759

10.1177/1352458510366014 | PMID 20427417 Get It

The Effect of Radioscapholunate Fusion On Wrist Movement and the Subsequent Effects of Distal Scaphoidectomy and Triquetrectomy
Berkhout, Merel J.-L. , Shaw, Miranda N., Berglund, Lars , An, Kai‐Nan , Berger, Richard A. , Ritt, Marco J.P.F.

Journal of Hand Surgery (European Volume) | April 28, 2010 | Volume: 35 | Issue: 9 | Pages: 740-745

10.1177/1753193410370926 | PMID 20427404 Get It

Radioscapholunate arthrodesis is a salvage procedure indicated for osteoarthritis of the radiocarpal joint involving the lunate facet of the radius. This cadaver study examines changes in wrist motion resulting from radioscapholunate arthrodesis, and the effects of surgical techniques to improve the range of motion. Simulated radioscapholunate arthrodesis, distal scaphoidectomy and triquetrectomy were carried out sequentially on six cadaver forearms and measurements (maximum flexion/extension and radial/ulnar deviation) were taken in the intact situation and after each surgical step using a magnetic tracking device. Radioscapholunate arthrodesis diminishes the amplitudes of movements of the wrist in all directions, but range of motion in the radioscapholunate fused wrist improves after scaphoidectomy and improves further after triquetrectomy (88% of original flexion/extension and 98% of original radial/ulnar deviation). Radioscapholunate arthrodesis causes a significant change in kinematics between the hamate and the triquetrum in flexion/extension.
Prospects for the Use of ATR Inhibitors to Treat Cancer
Wagner, Jill M., Kaufmann, Scott H.

Pharmaceuticals | April 28, 2010 | Volume: 3 | Issue: 5 | Pages: 1311-1334

10.3390/ph3051311 | PMID 27713304 Get It

ATR is an apical kinase in one of the DNA-damage induced checkpoint pathways. Despite the development of inhibitors of kinases structurally related to ATR, as well as inhibitors of the ATR substrate Chk1, no ATR inhibitors have yet been developed. Here we review the effects of ATR downregulation in cancer cells and discuss the potential for development of ATR inhibitors for clinical use.
Satisfaction Ratings After Receiving Internet-Based Cognitive Rehabilitation in Persons with Memory Impairments After Severe Acquired Brain Injury
Bergquist, Thomas F. , Thompson, Kelsey R. , Gehl, Carissa , Pineda, Jorge Munoz

Telemedicine and e-Health | April 26, 2010 | Volume: 16 | Issue: 4 | Pages: 417-423

10.1089/tmj.2009.0118 | PMID 20420542 Get It

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women
Rajkumar, S. Vincent , Kyle, Robert A. , Katzmann, Jerry A., Dispenzieri, Angela , Goldin, Lynn R. , Caporaso, Neil E. , Fraumeni, Joseph F., Blot, William J. , Signorello, Lisa B., Landgren, Ola , Pfeiffer, Ruth M. , Cai, Qiuyin , Rajkumar, S Vincent , Dispenzieri, Angela

Blood | April 26, 2010 | Volume: 116 | Issue: 7 | Pages: 1056-1059

10.1182/blood-2010-01-262394 | PMID 20421448 Get It

Abstract Obesity and black race have been associated with excess risk of multiple myeloma. The association of obesity with monoclonal gammopathy of undetermined significance (MGUS) is unknown. Further, it is not known whether the increased risk of multiple myeloma and MGUS in blacks is related to socioeconomic status, genetic susceptibility, or both. We screened 1000 black and 996 white women (range, 40-79 years) of similar socioeconomic status for MGUS; the aim of the study was to assess MGUS risk in relation to obesity and race. A total of 39 (3.9%) blacks and 21 (2.1%) whites had MGUS. On multivariate analysis, obesity (odds ratio [OR] = 1.8; P = .04), black race (OR = 1.8; P = .04), and increasing age (> 55 vs < 43 years; OR = 2.5; P = .03) were independently associated with an excess risk of MGUS. Our findings support the hypothesis that obesity is etiologically linked to myelomagenesis. The 2-fold excess of MGUS among blacks compared with whites of similar socioeconomic status supports a role for susceptibility genes in MGUS.
New daily-persistent headache
Young, William B. , Swanson, Jerry W.

Neurology | April 26, 2010 | Volume: 74 | Issue: 17 | Pages: 1338-1339

10.1212/wnl.0b013e3181de7fb9 | PMID 20421577 Get It

Factors influencing time to death after withdrawal of life support in neurocritical patients
Thapa, Prabin , Mandrekar, Jay , Yee, Anne Hway Ann , Rabinstein, Alejandro A. , Wijdicks, Eelco F. M.

Neurology | April 26, 2010 | Volume: 74 | Issue: 17 | Pages: 1380-1385

10.1212/wnl.0b013e3181dad5f0 | PMID 20421582 Get It